|
|
Blood, 1 January 2004, Vol. 103, No. 1, pp. 366.
 Previous Article | Table of Contents
CORRESPONDENCE
To the editor:
Fetal origin of the GATA1 mutation in identical twins with transient myeloproliferative disorder and acute megakaryoblastic leukemia accompanying Down syndrome
GATA1 mutations have been found in almost all cases of transient myeloproliferative disorder (TMD) and acute megakaryoblastic leukemia (AMKL) accompanying Down syndrome (DS).1-6 The mutations of the GATA1 gene, which is located on chromosome X, may occur prenatally or perinatally in individuals with TMD. Recently, Rainis et al4 reported that the same GATA1 mutation was found in identical twins with AMKL and acquired trisomy 21. This suggested that the mutation occurred in one of the twins in utero, that this twin did not have DS, and that preleukemic cells migrated to the other twin through embryonic blood connections.4,7 However, no unambiguous evidence has yet been presented for the prenatal timing of the GATA1 mutation in the patient with TMD and DS. We recently encountered identical twin females who had TMD with DS.
The 34-year-old mother was admitted to our hospital because of threatened premature delivery at 29 weeks of gestation. Because ultrasonography revealed hydrops fetalis in one of the twins, they were delivered by cesarean section at 32 weeks of gestation. Both of the twins showed leukocytosis from birth and were diagnosed as TMD. We analyzed the GATA1 mutation in peripheral blood samples from both patients. Written informed consent was obtained from their parents. Genomic DNA was extracted and cDNA was constructed, and then polymerase chain reaction (PCR) was performed and the products were sequenced directly, as described previously.6 Both patients had an identical mutation in the GATA1 gene. An insertion of 20 nucleotides corresponding to a sequence in exon 2 of the GATA1 gene was detected, resulting in the introduction of a premature stop codon in the gene sequence encoding the N-terminal activation domain (Figure 1). Both cases evolved to myelodysplastic syndrome after spontaneous resolution 13 months later, and the older twin sister died of pulmonary bleeding because of uncontrolled pulmonary hypertension. The other twin's disease evolved to AMKL at the age of 15 months. The identical mutation was also found in her AMKL blast cells. This unique GATA1 mutation found in identical twin females provides unequivocal evidence that cases of TMD in identical twins have a common clonal origin. The only plausible explanation is as follows: following initiation of TMD in one twin fetus, clonal progeny spread to the cotwin via vascular anastomoses within a single, monochorionic placenta, like those found in cases of leukemia in infantile identical twins.8,9 Our results provide definitive evidence that GATA1 mutations occur in utero in cases of AMKL with DS.
View larger version (38K):
[in this window]
[in a new window]
|
Figure 1.. An identical GATA1 mutation in twins with TMD accompanying DS. (A) Direct sequence analysis of cDNA and genomic DNA from TMD blast cells of identical twins with DS showed that 20 nucleotides of the duplicated sequences were inserted in exon 2 of the GATA1 gene in both patients. (B-C) The mutation resulted in the introduction of a premature stop codon in the gene sequence encoding the N-terminal activation domain. The predicted protein, GATA-1s, lacks the transactivation domain.
|
|
Akira Shimada,
Gang Xu,
Tsutomu Toki,
Hirokazu Kimura,
Yasuhide Hayashi, and
Etsuro Ito
Correspondence: Akira Shimada, Department of Hematology and Oncology, Gunma Children's Medical Center, Gunma, Japan; e-mail: ashimada{at}gcmc.pref.gunma.jp
References
- Wechsler J, Greene M, McDevitt MA, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet. 2002;32: 148-152.[CrossRef][Medline]
[Order article via Infotrieve]
- Mundschau G, Gurbuxani S, Gamis AS, et al. Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis. Blood. 2003;101: 4298-4300.[Abstract/Free Full Text]
- Hitzler JK, Cheung J, Li Y, et al. GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. Blood. 2003;101: 4301-4304.[Abstract/Free Full Text]
- Rainis L, Bercovich D, Strehl S, et al. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Blood. 2003;102: 981-986.[Abstract/Free Full Text]
- Groet J, McElwaine S, Spinelli M, et al. Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder. Lancet. 2003;361: 1617-1620.[CrossRef][Medline]
[Order article via Infotrieve]
- Xu G, Nagano M, Kanezaki R, et al. Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down's syndrome. Blood. 2003;102: 2960-2968.[Abstract/Free Full Text]
- Stark B, Jeison M, Preudhomme C, et al. Acquired trisomy 21 and distinct clonal evolution in acute megakaryoblastic leukaemia in young monozygotic twins. Br J Haematol. 2002;118: 1082-1086.[CrossRef][Medline]
[Order article via Infotrieve]
- Wiemels JL, Cazzaniga G, Daniotti M, et al. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet. 1999;354: 1499-1503.[CrossRef][Medline]
[Order article via Infotrieve]
- Greaves M, Maia AT, Wiemels JL, Ford AM. Leukemia in twins: lessons in natural history. Blood. 2003;102: 2321-2333.[Abstract/Free Full Text]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
D. C. Cabelof, H. V. Patel, Q. Chen, H. van Remmen, L. H. Matherly, Y. Ge, and J. W. Taub
Mutational spectrum at GATA1 provides insights into mutagenesis and leukemogenesis in Down syndrome
Blood,
September 24, 2009;
114(13):
2753 - 2763.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. C. Xavier, Y. Ge, and J. W. Taub
Down Syndrome and Malignancies: A Unique Clinical Relationship: A Paper from the 2008 William Beaumont Hospital Symposium on Molecular Pathology
J. Mol. Diagn.,
September 1, 2009;
11(5):
371 - 380.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Kearney, D. Gonzalez De Castro, J. Yeung, J. Procter, S. W. Horsley, M. Eguchi-Ishimae, C. M. Bateman, K. Anderson, T. Chaplin, B. D. Young, et al.
Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia
Blood,
January 15, 2009;
113(3):
646 - 648.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Pine, Q. Guo, C. Yin, S. Jayabose, C. M. Druschel, and C. Sandoval
Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome
Blood,
September 15, 2007;
110(6):
2128 - 2131.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Groet, C. Mulligan, M. Spinelli, A. Serra, S. McElwaine, F. E. Cotter, F. Dagna-Bricarelli, G. Saglio, G. Basso, and D. Nizetic
Independent clones at separable stages of differentiation, bearing different GATA1 mutations, in the same TMD patient with Down syndrome
Blood,
September 1, 2005;
106(5):
1887 - 1888.
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Pan, O. Ohneda, K. Ohneda, F. Lindeboom, F. Iwata, R. Shimizu, M. Nagano, N. Suwabe, S. Philipsen, K.-C. Lim, et al.
Graded Levels of GATA-1 Expression Modulate Survival, Proliferation, and Differentiation of Erythroid Progenitors
J. Biol. Chem.,
June 10, 2005;
280(23):
22385 - 22394.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. W. Taub, G. Mundschau, Y. Ge, J. M. Poulik, F. Qureshi, T. Jensen, S. J. James, L. H. Matherly, J. Wechsler, and J. D. Crispino
Prenatal origin of GATA1 mutations may be an initiating step in the development of megakaryocytic leukemia in Down syndrome
Blood,
September 1, 2004;
104(5):
1588 - 1589.
[Full Text]
[PDF]
|
|
|
|
|
